Arrowhead Pharmaceuticals
Trade Arrowhead Pharmaceuticals 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ARWR
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC.
ARWR Key Statistics
Stock Snapshot
With a market cap of 9.33B, Arrowhead Pharmaceuticals(ARWR) trades at $66.07. The stock has a price-to-earnings ratio of -29.45.
On 2026-09-25, Arrowhead Pharmaceuticals(ARWR) stock traded between a low of $65.46 and a high of $67.45. Shares are currently priced at $66.07, which is +0.9% above the low and -2.0% below the high.
The Arrowhead Pharmaceuticals(ARWR)'s current trading volume is 1.39M, compared to an average daily volume of 2.9M.
During the past year, Arrowhead Pharmaceuticals(ARWR) stock moved between $31.46 at its lowest and $95.49 at its peak.
During the past year, Arrowhead Pharmaceuticals(ARWR) stock moved between $31.46 at its lowest and $95.49 at its peak.
ARWR News
...
Arrowhead Pharmaceuticals reported interim Phase 1/2a data for ARO-DIMER-PA, showing single-dose dual gene silencing of PCSK9 by 72% and APOC3 by 88%, with no d...
Analyst ratings
94%
of 16 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.